Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'
Psychiatry Clin Neurosci
.
2020 Mar;74(3):219-220.
doi: 10.1111/pcn.12971.
Epub 2020 Jan 25.
Authors
Susumu Higuchi
1
,
Hisatsugu Miyata
2
,
Takako Hayashi
3
Affiliations
1
National Hospital Organization, Kurihama Medical and Addiction Center, Yokosuka, Japan.
2
Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan.
3
Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan.
PMID:
31876051
PMCID:
PMC7064995
DOI:
10.1111/pcn.12971
No abstract available
Publication types
Letter
Comment
MeSH terms
Alcohol Drinking
Alcoholism*
Humans
Naltrexone / analogs & derivatives
Substances
Naltrexone
nalmefene